RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility.

MLA

Yu, Jianxiu, et al. “RhoGDI SUMOylation at Lys-138 Increases Its Binding Activity to Rho GTPase and Its Inhibiting Cancer Cell Motility.” The Journal of Biological Chemistry, vol. 287, no. 17, Apr. 2012, pp. 13752–60. EBSCOhost, https://doi.org/10.1074/jbc.M111.337469.

APA

Yu, J., Zhang, D., Liu, J., Li, J., Yu, Y., Wu, X.-R., & Huang, C. (2012). RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility. The Journal of Biological Chemistry, 287(17), 13752–13760. https://doi.org/10.1074/jbc.M111.337469

Chicago

Yu, Jianxiu, Dongyun Zhang, Jinyi Liu, Jingxia Li, Yonghui Yu, Xue-Ru Wu, and Chuanshu Huang. 2012. “RhoGDI SUMOylation at Lys-138 Increases Its Binding Activity to Rho GTPase and Its Inhibiting Cancer Cell Motility.” The Journal of Biological Chemistry 287 (17): 13752–60. doi:10.1074/jbc.M111.337469.